Sfoglia per Autore
Reduction of the aplastic phase and hospitalization in patients receiving PBSC autotransplantation followed by erythropoietin plus filgrastim: A matched analysis of 79 consecutive procedures
2003-01-01 Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Cecchi, S; Spitaleri, L; Troiani, E; Masia, Mc; Leoni, Pietro
Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG
2003-01-01 Santini, G; Olivieri, Attilio; Majolino, I; Congiu, A; Chisesi, T; De Souza, C; Patti, C; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V.
An outpatient model of autologous stem cell transplantation with double peripheral blood stem cell reinfusion and early growth factor administration
2003-01-01 Olivieri, Attilio; Montanari, M; Capelli, D; Lucesole, M; Spitaleri, L; Scortechini, I; Cecchi, S; Gini, G; Leoni, Pietro
Chimerism evaluation in the lymphoemopoietic subpopulation after allogeneic reduced-intensity stem cell transplantation: a comparison of two different regimens including and not fludarabine
2003-01-01 Lucesole, M; Poloni, Antonella; Capelli, D; Gini, G; Spitaleri, L; Cecchi, S; Montanari, M; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors.
2003-01-01 Majolino, I; Corradini, P; Scimè, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marcenò, R; Santoro, A; Pileri, A.
Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
2003-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P.
In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease.
2003-01-01 Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P.
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate
2003-01-01 Ladetto, M; Ricca, I; Benedetti, F; Liberati, M; Vitolo, U; Musso, M; Gallamini, A; Callea, V; Pavone, V; Almici, C; Di Raimondo, F; De Sousa, C; Fioritoni, G; Majolino, I; Olivieri, Attilio; Patti, C; Pogliani, E; Astolfi, M; Boccadoro, M; Gianni, Am; Corradini, P; Tarella, C.
Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma
2003-01-01 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, E; Rambaldi, A; Locasciulli, A; Falda, M; Santoro, A; Scime, R; Gianni, Am
Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation
2003-01-01 Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio
Combination therapy with Caelyx, dexamethasone and thalidomide (CDT) for multiple myeloma (MM): Preliminary results of a phase II-III study.
2003-01-01 Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Barulli, S; Capelli, D; Rupoli, S; Leoni, Pietro
Long-term results of a multicenter study of autologous selected PBSC transplantation in advanced CLL patients
2003-01-01 Scime, R; Tringali, S; Santoro, A; Cavallaro, A; Musso, M; Basirico, R; Di Bella, R; Indovina, A; Crescimanno, A; Olivieri, Attilio; Donelli, A.
Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine.
2003-01-01 Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell trasplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80° C degrees.
2003-01-01 Montanari, M; Capelli, D; Poloni, Antonella; Massidda, D; Brunori, M; Spitaleri, L; Offidani, M; Lucesole, M; Masia, M. C.; Balducci, F; Refe, C; Piani, M; Leoni, Pietro; Olivieri, Attilio
Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: Our experience [Trapianto autologo di cellule staminali periferiche in un paziente con sclerosi sistemica diffusa: Nostra esperienza]
2004-01-01 Giorgetti, F.; Minnucci, M. L.; Santori, P.; Ercoli, L.; Rossi, M.; Del Papa, M.; Morico, G.; Squadroni, P.; Olivieri, Attilio; Centurioni, R.
Post-transplant events Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders
2004-01-01 Olivieri, Attilio; I., Scortechini; D., Capelli; M., Montanari; M., Lucesole; G., Gini; M., Troiani; M., Offidani; Poloni, Antonella; Mc, Masia; Raggetti, Gianmario; Leoni, Pietro
Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias
2004-01-01 Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio
Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients
2004-01-01 Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro
Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease
2004-01-01 Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R.
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.
2004-01-01 Olivieri, Attilio; Brunori, M; Capelli, D; Montanari, M; Massidda, D; Gini, G; Lucesole, M; Poloni, Antonella; Offidani, M; Candela, M; Centurioni, R; Leoni, Pietro
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Reduction of the aplastic phase and hospitalization in patients receiving PBSC autotransplantation followed by erythropoietin plus filgrastim: A matched analysis of 79 consecutive procedures | 1-gen-2003 | Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Cecchi, S; Spitaleri, L; Troiani, E; Masia, Mc; Leoni, Pietro | |
Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG | 1-gen-2003 | Santini, G; Olivieri, Attilio; Majolino, I; Congiu, A; Chisesi, T; De Souza, C; Patti, C; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V. | |
An outpatient model of autologous stem cell transplantation with double peripheral blood stem cell reinfusion and early growth factor administration | 1-gen-2003 | Olivieri, Attilio; Montanari, M; Capelli, D; Lucesole, M; Spitaleri, L; Scortechini, I; Cecchi, S; Gini, G; Leoni, Pietro | |
Chimerism evaluation in the lymphoemopoietic subpopulation after allogeneic reduced-intensity stem cell transplantation: a comparison of two different regimens including and not fludarabine | 1-gen-2003 | Lucesole, M; Poloni, Antonella; Capelli, D; Gini, G; Spitaleri, L; Cecchi, S; Montanari, M; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio | |
High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors. | 1-gen-2003 | Majolino, I; Corradini, P; Scimè, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marcenò, R; Santoro, A; Pileri, A. | |
Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma. | 1-gen-2003 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P. | |
In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease. | 1-gen-2003 | Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P. | |
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate | 1-gen-2003 | Ladetto, M; Ricca, I; Benedetti, F; Liberati, M; Vitolo, U; Musso, M; Gallamini, A; Callea, V; Pavone, V; Almici, C; Di Raimondo, F; De Sousa, C; Fioritoni, G; Majolino, I; Olivieri, Attilio; Patti, C; Pogliani, E; Astolfi, M; Boccadoro, M; Gianni, Am; Corradini, P; Tarella, C. | |
Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma | 1-gen-2003 | Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, E; Rambaldi, A; Locasciulli, A; Falda, M; Santoro, A; Scime, R; Gianni, Am | |
Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation | 1-gen-2003 | Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio | |
Combination therapy with Caelyx, dexamethasone and thalidomide (CDT) for multiple myeloma (MM): Preliminary results of a phase II-III study. | 1-gen-2003 | Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Barulli, S; Capelli, D; Rupoli, S; Leoni, Pietro | |
Long-term results of a multicenter study of autologous selected PBSC transplantation in advanced CLL patients | 1-gen-2003 | Scime, R; Tringali, S; Santoro, A; Cavallaro, A; Musso, M; Basirico, R; Di Bella, R; Indovina, A; Crescimanno, A; Olivieri, Attilio; Donelli, A. | |
Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine. | 1-gen-2003 | Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio | |
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell trasplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80° C degrees. | 1-gen-2003 | Montanari, M; Capelli, D; Poloni, Antonella; Massidda, D; Brunori, M; Spitaleri, L; Offidani, M; Lucesole, M; Masia, M. C.; Balducci, F; Refe, C; Piani, M; Leoni, Pietro; Olivieri, Attilio | |
Autologus peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: Our experience [Trapianto autologo di cellule staminali periferiche in un paziente con sclerosi sistemica diffusa: Nostra esperienza] | 1-gen-2004 | Giorgetti, F.; Minnucci, M. L.; Santori, P.; Ercoli, L.; Rossi, M.; Del Papa, M.; Morico, G.; Squadroni, P.; Olivieri, Attilio; Centurioni, R. | |
Post-transplant events Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders | 1-gen-2004 | Olivieri, Attilio; I., Scortechini; D., Capelli; M., Montanari; M., Lucesole; G., Gini; M., Troiani; M., Offidani; Poloni, Antonella; Mc, Masia; Raggetti, Gianmario; Leoni, Pietro | |
Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias | 1-gen-2004 | Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio | |
Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients | 1-gen-2004 | Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro | |
Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease | 1-gen-2004 | Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R. | |
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. | 1-gen-2004 | Olivieri, Attilio; Brunori, M; Capelli, D; Montanari, M; Massidda, D; Gini, G; Lucesole, M; Poloni, Antonella; Offidani, M; Candela, M; Centurioni, R; Leoni, Pietro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile